Integrated bioinformatics and immunohistochemical analysis reveal that S100A16 is correlated with mutational burden, immune evasion, and P53 expression in gastric adenocarcinoma
International Journal of Clinical and Experimental Pathology · 2026
DOI: 10.62347/cecr4915 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Clinical and Experimental Pathology, 2026. Verfasst von Erle Zhou und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Binzhou Medical University Hospital Binzhou 256603, Shandong, China. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathology, Binzhou Medical University Hospital Binzhou 256603, Shandong, China.
- Department of Pathology, Qingdao Women and Children's Hospital Qingdao 266034, Shandong, China.
- Shandong Modern College Jinan 250104, Shandong, China.
Zitieren
APA
Zhou, E., Wang, S., Su, N., Tong, M., Wang, S., & Cao, Z. (2026). Integrated bioinformatics and immunohistochemical analysis reveal that S100A16 is correlated with mutational burden, immune evasion, and P53 expression in gastric adenocarcinoma. International Journal of Clinical and Experimental Pathology. https://doi.org/10.62347/cecr4915
Vancouver
Zhou E, Wang S, Su N, Tong M, Wang S, Cao Z. Integrated bioinformatics and immunohistochemical analysis reveal that S100A16 is correlated with mutational burden, immune evasion, and P53 expression in gastric adenocarcinoma. International Journal of Clinical and Experimental Pathology. 2026. doi:10.62347/cecr4915
BibTeX
@article{Zhou2026,
author = {Zhou, Erle and Wang, Sijia and Su, Nana and Tong, Meichen and Wang, Shasha and Cao, Zhang},
title = {Integrated bioinformatics and immunohistochemical analysis reveal that S100A16 is correlated with mutational burden, immune evasion, and P53 expression in gastric adenocarcinoma},
journal = {International Journal of Clinical and Experimental Pathology},
year = {2026},
doi = {10.62347/cecr4915}
}
EUVIMED